Sixth joint meeting of J-Cap and CaPSURE-A multinational perspective on prostate cancer management and patient outcomes

Hideyuki Akaza, Shiro Hinotsu, Matthew R. Cooperberg, Byung Ha Chung, Ji Youl Lee, Rainy Umbas, Taiji Tsukamoto, Mikio Namiki, Peter Carroll

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

This report summarizes the presentations and discussions that took place at the Sixth Joint Meeting of J-CaP and CaPSURE held in San Francisco, USA, in August 2012. The J-CaP and CaPSURE Joint Initiative was established in 2007 with the objective of analyzing, reviewing, comparing and contrasting data for prostate cancer patients from Japan and the USA within the two important large-scale, longitudinal, observational databases-J-CaP and CaPSURE. Since this initial collaboration between teams in the USA and Japan, the initiative has now expanded to include representatives of other Asian countries, several of whom have either established or are planning their own national prostate cancer databases. Several key topics were considered at this Sixth Joint Meeting including the current status of the J-CaP and CaPSURE databases and opportunities for collaboration with the more recently developed Asian prostate cancer databases. The latest comparative data from J-CaP and CaPSURE regarding outcomes following androgen deprivation therapy and combined androgen blockade were also reviewed. The possibility of a global chemoprevention trial to investigate the influence of soy isoflavones on prostate cancer incidence was considered. In addition, the ongoing debate regarding the role of screening and the use of active surveillance as a treatment option in the USA was discussed. The collaborators agreed that sharing of data and treatment practices on a global scale would undoubtedly benefit the clinical management of prostate cancer patients worldwide.

Original languageEnglish
Pages (from-to)756-766
Number of pages11
JournalJapanese Journal of Clinical Oncology
Volume43
Issue number7
DOIs
Publication statusPublished - 2013 Jul 1

Fingerprint

Internationality
Prostatic Neoplasms
Databases
Androgens
Japan
Isoflavones
San Francisco
Information Dissemination
Chemoprevention
Therapeutics
Incidence

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Akaza, Hideyuki ; Hinotsu, Shiro ; Cooperberg, Matthew R. ; Chung, Byung Ha ; Lee, Ji Youl ; Umbas, Rainy ; Tsukamoto, Taiji ; Namiki, Mikio ; Carroll, Peter. / Sixth joint meeting of J-Cap and CaPSURE-A multinational perspective on prostate cancer management and patient outcomes. In: Japanese Journal of Clinical Oncology. 2013 ; Vol. 43, No. 7. pp. 756-766.
@article{b5c1c057ec9a4974830d38b3baaa6e9b,
title = "Sixth joint meeting of J-Cap and CaPSURE-A multinational perspective on prostate cancer management and patient outcomes",
abstract = "This report summarizes the presentations and discussions that took place at the Sixth Joint Meeting of J-CaP and CaPSURE held in San Francisco, USA, in August 2012. The J-CaP and CaPSURE Joint Initiative was established in 2007 with the objective of analyzing, reviewing, comparing and contrasting data for prostate cancer patients from Japan and the USA within the two important large-scale, longitudinal, observational databases-J-CaP and CaPSURE. Since this initial collaboration between teams in the USA and Japan, the initiative has now expanded to include representatives of other Asian countries, several of whom have either established or are planning their own national prostate cancer databases. Several key topics were considered at this Sixth Joint Meeting including the current status of the J-CaP and CaPSURE databases and opportunities for collaboration with the more recently developed Asian prostate cancer databases. The latest comparative data from J-CaP and CaPSURE regarding outcomes following androgen deprivation therapy and combined androgen blockade were also reviewed. The possibility of a global chemoprevention trial to investigate the influence of soy isoflavones on prostate cancer incidence was considered. In addition, the ongoing debate regarding the role of screening and the use of active surveillance as a treatment option in the USA was discussed. The collaborators agreed that sharing of data and treatment practices on a global scale would undoubtedly benefit the clinical management of prostate cancer patients worldwide.",
author = "Hideyuki Akaza and Shiro Hinotsu and Cooperberg, {Matthew R.} and Chung, {Byung Ha} and Lee, {Ji Youl} and Rainy Umbas and Taiji Tsukamoto and Mikio Namiki and Peter Carroll",
year = "2013",
month = "7",
day = "1",
doi = "10.1093/jjco/hyt071",
language = "English",
volume = "43",
pages = "756--766",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "7",

}

Akaza, H, Hinotsu, S, Cooperberg, MR, Chung, BH, Lee, JY, Umbas, R, Tsukamoto, T, Namiki, M & Carroll, P 2013, 'Sixth joint meeting of J-Cap and CaPSURE-A multinational perspective on prostate cancer management and patient outcomes', Japanese Journal of Clinical Oncology, vol. 43, no. 7, pp. 756-766. https://doi.org/10.1093/jjco/hyt071

Sixth joint meeting of J-Cap and CaPSURE-A multinational perspective on prostate cancer management and patient outcomes. / Akaza, Hideyuki; Hinotsu, Shiro; Cooperberg, Matthew R.; Chung, Byung Ha; Lee, Ji Youl; Umbas, Rainy; Tsukamoto, Taiji; Namiki, Mikio; Carroll, Peter.

In: Japanese Journal of Clinical Oncology, Vol. 43, No. 7, 01.07.2013, p. 756-766.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sixth joint meeting of J-Cap and CaPSURE-A multinational perspective on prostate cancer management and patient outcomes

AU - Akaza, Hideyuki

AU - Hinotsu, Shiro

AU - Cooperberg, Matthew R.

AU - Chung, Byung Ha

AU - Lee, Ji Youl

AU - Umbas, Rainy

AU - Tsukamoto, Taiji

AU - Namiki, Mikio

AU - Carroll, Peter

PY - 2013/7/1

Y1 - 2013/7/1

N2 - This report summarizes the presentations and discussions that took place at the Sixth Joint Meeting of J-CaP and CaPSURE held in San Francisco, USA, in August 2012. The J-CaP and CaPSURE Joint Initiative was established in 2007 with the objective of analyzing, reviewing, comparing and contrasting data for prostate cancer patients from Japan and the USA within the two important large-scale, longitudinal, observational databases-J-CaP and CaPSURE. Since this initial collaboration between teams in the USA and Japan, the initiative has now expanded to include representatives of other Asian countries, several of whom have either established or are planning their own national prostate cancer databases. Several key topics were considered at this Sixth Joint Meeting including the current status of the J-CaP and CaPSURE databases and opportunities for collaboration with the more recently developed Asian prostate cancer databases. The latest comparative data from J-CaP and CaPSURE regarding outcomes following androgen deprivation therapy and combined androgen blockade were also reviewed. The possibility of a global chemoprevention trial to investigate the influence of soy isoflavones on prostate cancer incidence was considered. In addition, the ongoing debate regarding the role of screening and the use of active surveillance as a treatment option in the USA was discussed. The collaborators agreed that sharing of data and treatment practices on a global scale would undoubtedly benefit the clinical management of prostate cancer patients worldwide.

AB - This report summarizes the presentations and discussions that took place at the Sixth Joint Meeting of J-CaP and CaPSURE held in San Francisco, USA, in August 2012. The J-CaP and CaPSURE Joint Initiative was established in 2007 with the objective of analyzing, reviewing, comparing and contrasting data for prostate cancer patients from Japan and the USA within the two important large-scale, longitudinal, observational databases-J-CaP and CaPSURE. Since this initial collaboration between teams in the USA and Japan, the initiative has now expanded to include representatives of other Asian countries, several of whom have either established or are planning their own national prostate cancer databases. Several key topics were considered at this Sixth Joint Meeting including the current status of the J-CaP and CaPSURE databases and opportunities for collaboration with the more recently developed Asian prostate cancer databases. The latest comparative data from J-CaP and CaPSURE regarding outcomes following androgen deprivation therapy and combined androgen blockade were also reviewed. The possibility of a global chemoprevention trial to investigate the influence of soy isoflavones on prostate cancer incidence was considered. In addition, the ongoing debate regarding the role of screening and the use of active surveillance as a treatment option in the USA was discussed. The collaborators agreed that sharing of data and treatment practices on a global scale would undoubtedly benefit the clinical management of prostate cancer patients worldwide.

UR - http://www.scopus.com/inward/record.url?scp=84880141128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880141128&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyt071

DO - 10.1093/jjco/hyt071

M3 - Article

C2 - 23723314

AN - SCOPUS:84880141128

VL - 43

SP - 756

EP - 766

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 7

ER -